📂 Drugs
NKG2D-LIF6 chimera — Definition
NKG2D-LIF6 kimerası / NKG2D-LIF6 chimera
NKG2D-LIF6 is a genetically designed fusion protein that combines LIF6 (Lukemia Inhibitor Factor 6) protein with the binding zone of NKG2D receptor. This structure was developed to be used in cancer treatment by directing immune cells to tumor cells. Kimerik protein connects to cancer cells that express NKG2D ligands and trigger cell death through LIF6. In clinical pre-operative studies, it is researched as an immunotherapy agent in hematological malignantities.
Frequently Asked Questions
❓ What is NKG2D-LIF6 kimerası?
NKG2D-LIF6 kimerası; nKG2D-LIF6 is a genetically designed fusion protein that combines LIF6 (Lukemia Inhibitor Factor 6) protein with the binding zone of NKG2D receptor. This structure was developed to be used in cancer treatment by directing immune cells to tumor cells. Kimerik protein connects to cancer cells that express NKG2D ligands and trigger cell death through LIF6. In clinical pre-operative studies, it is researched as an immunotherapy agent in hematological malignantities.
❓ What is NKG2D-LIF6 chimera in Turkish?
The Turkish equivalent of "NKG2D-LIF6 chimera" is NKG2D-LIF6 kimerası.
❓ Which medical field is NKG2D-LIF6 kimerası related to?
This term belongs to the Drugs category.